Hepatitis C epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Hepatitis C}} {{CMG}}; '''Assistant Editor-In-Chief:''' Nina Axiotakis [mailto:naxiotak@oberlin.edu] == Epidemiology == Hepatitis C infects an estimated 170 million people ...")
 
No edit summary
Line 12: Line 12:
Egypt has the highest seroprevalence for HCV, up to 20% in some areas. There is a hypothesis that the high prevalence is linked to a now-discontinued mass-treatment campaign for [[schistosomiasis]], which is endemic in that country.<!--
Egypt has the highest seroprevalence for HCV, up to 20% in some areas. There is a hypothesis that the high prevalence is linked to a now-discontinued mass-treatment campaign for [[schistosomiasis]], which is endemic in that country.<!--
   --><ref name="frank">{{cite journal | author = Frank C, Mohamed M, Strickland G, Lavanchy D, Arthur R, Magder L, El Khoby T, Abdel-Wahab Y, Aly Ohn E, Anwar W, Sallam I | title = The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. | journal = Lancet | volume = 355 | issue = 9207 | pages = 887-91 | year = 2000 | id = PMID 10752705}}</ref>
   --><ref name="frank">{{cite journal | author = Frank C, Mohamed M, Strickland G, Lavanchy D, Arthur R, Magder L, El Khoby T, Abdel-Wahab Y, Aly Ohn E, Anwar W, Sallam I | title = The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. | journal = Lancet | volume = 355 | issue = 9207 | pages = 887-91 | year = 2000 | id = PMID 10752705}}</ref>
In 2007, there were an estimated 17,000 new Hepatitis C virus infections in the United States. However, the official number of reported Hepatitis C cases is much lower. Many people who are infected never have symptoms and therefore never come to the attention of medical or public health officials.<ref>[http://www.cdc.gov/hepatitis/C/cFAQ.htm#statistics CDC]</ref>
An estimated 3.2 million persons in the United States have chronic Hepatitis C virus infection. Most people do not know they are infected because they don’t look or feel sick.<ref>[http://www.cdc.gov/hepatitis/C/cFAQ.htm#statistics CDC]<ref>
Approximately 75%–85% of people who become infected with Hepatitis C virus develop chronic infection.<ref>[http://www.cdc.gov/hepatitis/C/cFAQ.htm#statistics CDC]<ref>


==References==
==References==

Revision as of 15:03, 21 February 2012

Hepatitis Main Page

Hepatitis C

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology & Demographics

Risk Factors

Screening

Differentiating Hepatitis C from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Hepatitis C epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis C epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis C epidemiology and demographics

CDC on Hepatitis C epidemiology and demographics

Hepatitis C epidemiology and demographics in the news

Blogs on Hepatitis C epidemiology and demographics

Directions to Hospitals Treating Hepatitis C

Risk calculators and risk factors for Hepatitis C epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-In-Chief: Nina Axiotakis [2]

Epidemiology

Hepatitis C infects an estimated 170 million people worldwide and 4 million in the United States. There are about 35,000 to 185,000 new cases a year in the United States. Co-infection with HIV is common and rates among HIV positive populations are higher. 10,000-20,000 deaths a year in the United States are from HCV; expectations are that this mortality rate will increase, as those who were infected by transfusion before HCV testing become apparent. A survey conducted in California showed prevalence of up to 34% among prison inmates;[1] 82% of subjects diagnosed with hepatitis C have previously been in jail,[2] and transmission while in prison is well described.[3]

Egypt has the highest seroprevalence for HCV, up to 20% in some areas. There is a hypothesis that the high prevalence is linked to a now-discontinued mass-treatment campaign for schistosomiasis, which is endemic in that country.[4]

In 2007, there were an estimated 17,000 new Hepatitis C virus infections in the United States. However, the official number of reported Hepatitis C cases is much lower. Many people who are infected never have symptoms and therefore never come to the attention of medical or public health officials.[5]

An estimated 3.2 million persons in the United States have chronic Hepatitis C virus infection. Most people do not know they are infected because they don’t look or feel sick.<ref>CDC<ref>

Approximately 75%–85% of people who become infected with Hepatitis C virus develop chronic infection.<ref>CDC<ref>

References

  1. Ruiz J, Molitor F, Plagenhoef J (2002). "Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999". AIDS. 16 (16): 2236–8. PMID 12409752.
  2. Campbell J, Hagan H, Latka M, Garfein R, Golub E, Coady M, Thomas D, Strathdee S (2006). "High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities". Drug Alcohol Depend. 81 (3): 259–65. PMID 16129567.
  3. McGovern B, Wurcel A, Kim A, Schulze zur Wiesch J, Bica I, Zaman M, Timm J, Walker B, Lauer G (2006). "Acute hepatitis C virus infection in incarcerated injection drug users". Clin Infect Dis. 42 (12): 1663–70. PMID 16705568.
  4. Frank C, Mohamed M, Strickland G, Lavanchy D, Arthur R, Magder L, El Khoby T, Abdel-Wahab Y, Aly Ohn E, Anwar W, Sallam I (2000). "The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt". Lancet. 355 (9207): 887–91. PMID 10752705.
  5. CDC

Template:WH Template:WS